Skip to main content
. 2016 Jul 13;50(3):196–206. doi: 10.1007/s13139-016-0433-x

Fig. 3.

Fig. 3

F-18 flurpiridaz PET versus Tc-99m MIBI SPECT. Reversible perfusion defect in the anterior and antero-septal wall is readily seen in a patient with left anterior descending coronary artery occlusion using F-18 flurpiridaz PET but the perfusion abnormality is not clearly appreciated using Tc-99m MIBI SPECT. (Reprinted from [29] with permission of Elsevier)